Charles Wakeford

600 total citations
10 papers, 503 citations indexed

About

Charles Wakeford is a scholar working on Infectious Diseases, Virology and Pharmacology. According to data from OpenAlex, Charles Wakeford has authored 10 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 3 papers in Virology and 1 paper in Pharmacology. Recurrent topics in Charles Wakeford's work include HIV/AIDS drug development and treatment (5 papers), HIV Research and Treatment (3 papers) and HIV/AIDS Research and Interventions (2 papers). Charles Wakeford is often cited by papers focused on HIV/AIDS drug development and treatment (5 papers), HIV Research and Treatment (3 papers) and HIV/AIDS Research and Interventions (2 papers). Charles Wakeford collaborates with scholars based in United States, South Africa and United Kingdom. Charles Wakeford's co-authors include Franck Rousseau, Jeanette Harris, Laurene H. Wang, John Begley, Herve Momméja-Marin, Joseph Quinn, Ian Sanne, John Bartlett, Gary Maartens and Audrey L. Shaw and has published in prestigious journals such as The Journal of Infectious Diseases, Phytotherapy Research and AIDS Research and Human Retroviruses.

In The Last Decade

Charles Wakeford

10 papers receiving 483 citations

Peers

Charles Wakeford

VIROL

EPIDE

HEPAT

Malte Schütz United States

Rosa Ruiz-Valderas Spain

Valentina Montessori Canada

Rodica Van Solingen‐Ristea United States

L. Trentini Italy

D.M. Burger Netherlands

Daniel Seekins United States

Steve West United States

Michael L. Lim United States

Tsunefusa Hayashida Japan

Malte Schütz United States

Charles Wakeford

387 ×0.9

215 ×0.8

VIROL

186 ×1.6

EPIDE

99 ×1.7

26 ×0.5

HEPAT

Citations per year, relative to Charles Wakeford Charles Wakeford (= 1×) peers Malte Schütz

Countries citing papers authored by Charles Wakeford

Since Specialization

Citations

This map shows the geographic impact of Charles Wakeford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Wakeford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Wakeford more than expected).

Fields of papers citing papers by Charles Wakeford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Wakeford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Wakeford. The network helps show where Charles Wakeford may publish in the future.

Co-authorship network of co-authors of Charles Wakeford

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Wakeford. A scholar is included among the top collaborators of Charles Wakeford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Wakeford. Charles Wakeford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Wakeford, Charles, et al.. (2017). Beneficial effects of an investigational wristband containingSynsepalum dulcificum(miracle fruit) seed oil on the performance of hand and finger motor skills in healthy subjects: A randomized controlled preliminary study. Phytotherapy Research. 32(2). 321–332. 7 indexed citations

Wakeford, Charles, et al.. (2017). Effect of Miracle Fruit (Synsepalum dulcificum) Seed Oil (MFSO^®) on the Measurable Improvement of Hair Breakage in Women with Damaged Hair: A Randomized, Double-blind, Placebo-controlled, Eight-month Trial.. PubMed. 10(11). 39–48. 9 indexed citations

Wakeford, Charles. (2009). LEARNING BY DESIGN: FORMATS FOR ONLINE ENQUIRY AND PROBLEM SOLVING. 76(3-4). 2791–2797. 1 indexed citations

O’Neal, Wesley T., Kirsten White, Charles Wakeford, et al.. (2009). Mutations in the thumb–connection and RNase H domain of HIV type-1 reverse transcriptase of antiretroviral treatment-experienced patients. Antiviral Therapy. 14(2). 231–239. 19 indexed citations

Chang, Mark, et al.. (2007). Innovative Approaches in Drug Development. Journal of Biopharmaceutical Statistics. 17(5). 775–789. 5 indexed citations

Sanne, Ian, Herve Momméja-Marin, John E. Hinkle, et al.. (2005). Severe Hepatotoxicity Associated with Nevirapine Use in HIV‐Infected Subjects. The Journal of Infectious Diseases. 191(6). 825–829. 195 indexed citations

Wang, Laurene H., et al.. (2004). Pharmacokinetic and Pharmacodynamic Characteristics of Emtricitabine Support Its Once Daily Dosing for the Treatment of HIV Infection. AIDS Research and Human Retroviruses. 20(11). 1173–1182. 108 indexed citations

Wang, Laurene H., John Begley, Robert L. St. Claire, et al.. (2004). Pharmacokinetic and Pharmacodynamic Characteristics of Emtricitabine Support Its Once Daily Dosing for the Treatment of HIV Infection. AIDS Research and Human Retroviruses. 20(11). 1173–1182. 101 indexed citations

Rousseau, Franck, Charles Wakeford, Herve Momméja-Marin, et al.. (2003). Prospective Randomized Trial of Emtricitabine versus Lamivudine Short‐Term Monotherapy in Human Immunodeficiency Virus–Infected Patients. The Journal of Infectious Diseases. 188(11). 1652–1658. 54 indexed citations

10.

Thadani, Udho, Steven G. Chrysant, Thomas D. Giles, et al.. (1994). Duration of effects of isradipine during twice daily therapy in angina pectoris. Cardiovascular Drugs and Therapy. 8(2). 199–210. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact